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Regulation of the renal angiotensin II receptor gene in acute unilateral
ureteral obstruction. We have shown that acute (24-hr) unilateral
ureteral obstruction (UUO) induces the genes encoding for renin, in
juxtaglomerular apparatuses and in tubules, for angiotensin converting
enzyme in vascular endothelial cells, and for angiotensinogen in
perivascular fat. These molecular changes occur in temporal associa-
tion to marked reductions in renal blood flow (RBF) and glomerular
filtration rate (GFR), suggesting that angiotensin II (Ang H) is at least
partly responsible for the renal vasoconstriction. We tested the hypoth-
esis that down-regulation of the Ang II type-i receptor (AT1-R) gene
occurs in UUO in response to Ang II, by examining the effects of an
ACE inhibitor [lisinopril (Li), 5 mg/kg/day] and of the specific nonpep-
tidic AT1-R blocker, losartan (Lo) (10 mg/kg/day). UUO or sham
operated (which included manipulation but not obstruction of the
ureter) rats (S) were studied. Northern blot analysis of the steady state
concentration of AT1-R mRNA corrected for GAPDH mRNA showed
a marked decrease in receptor expression (—77%, N = 4, P < 0.01) in
the obstructed kidney (UUO) compared to S; sham diminished gene
expression modestly compared to the contralateral kidneys (C) of
UUO. In situ hybridization for AT1-R mRNA also showed diminished
expression in UUO compared to C kidneys (N = 4). Treatment of UUO
rats (N =4) with Lo increased AT1-R mRNA five times above the levels
in UUO rats receiving vehicle; the increase induced by Li was 50% that
of Lo; S (N = 4) and C (N = 4) did not change. Losartan, but not
vehicle treatment increased RBF (sixfold) and GFR (fivefold) in the
UUO kidneys. We conclude that UUO leads to down-regulation of
AT1-R mRNA, and that this effect is mediated by Ang II, which is also
responsible for a major component of the renal hemodynamic changes.
Some function of UUO or ureteral manipulation, possibly stretch or
nerve stimulation, differentially regulates the genes encoding for the
renin-angiotensin system in the kidney.
Acute (24 hr) unilateral ureteral obstruction (UUO) leads to a
progressive increase in renal vascular resistance (RVR) and a
marked decrease in renal blood flow (RB F) and glomerular
filtration rate (GFR) [1, 2]. Studies performed in the last decade
have demonstrated a role of several potent vasoactive sub-
stances in the renal hemodynamic changes of UUO, including
angiotensin (Ang) II [3], thromboxane A2 [4], prostaglandins
(PGE2, PGI2) [5, 6], bradykinin [71, atrial natnuretic peptide [8],
and nitric oxide [9]. A large body of evidence, however,
supports the concept that the renin angiotensin system (RAS) is
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the central modulator of the renal hemodynamic response to
UUO [3, 10, 11].
We have recently reported that UUO leads to enhanced
expression of RAS genes including those of renin (R), angioten-
sinogen (Ao) and angiotensin I-converting enzyme (ACE) in the
obstructed kidney [11]. Furthermore, losartan, a non-peptidic
Ang II type-i receptor (AT1-R) blocker, resulted in marked
recovery of renal function after release of 24-hours UUO in
awake rats [12]. These findings suggest that the RAS plays a
fundamental role in UUO and that some component thereof
(hemodynamic changes, stretch, pressure, obstruction to flow,
etc.) induces transcriptional or post-transcriptional changes in
RAS mRNAs. Evidence for increased production of Ang II in
the obstructed kidney has been obtained in pigs with acute
UUO and in rats with chronic UUO [10, 13]. Under conditions
of increased local Ang II production, increased AT1-R mRNA
expression would lead to increased synthesis of receptor mol-
ecules and would contribute to increased sensitivity and re-
sponsiveness to the vasoconstrictor actions of this peptide, and
worsen the decreased renal blood flow in UUO. Nevertheless,
the effect of acute UUO on the renal expression of the AT1-R
gene is unknown. The present study was designed to examine
the effect of UUO on AT1-R mRNA and to determine the role
of Ang II in the changes, if any, of the AT1-R gene expression.
In addition, we have examined the role Ang II on the renal
hemodynamics changes of UUO by testing the effect of losar-
tan.
Methods
Male Wistar rats weighing 150 to 200 g (Charles River
Laboratories, Wilmington, Massachusetts, USA) were used for
these experiments. The rats were housed individually in a room
providing 12-hour light and dark cycles and were maintained on
standard Purina rat pellets with free access to food and water at
all times prior to the experiment. General anesthesia was
induced by intraperstoneal injection of ketamine (100 mg/kg
body wt) and xylazine(lO mg/kg body wt), and the left ureter
was exposed through a small left flank incision and dissected
from its retroperitoneal site. Complete occlusion of the ureter
was performed by a 4-0 silk square knot (N = 12). The
abdominal incision was closed and animals were allowed to
recover prior to returning to their cages. Eight rats were sham
operated: ureter exposed and manipulated (naked-eye) as in the
experimental groups but not tied (N = 4); in one rat both sides
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Table 1. Renal hemodynamics in awake rats pretreated with vehicle





Vehicle Losartan(N=4) (N=4) (N=4) (N=4)
Obstructed 0.63 0.21 3.11 0.20 2.41 0.88 13.18 0.23
kidney
P <0.001 <0.001
Control 8.25 0.2! 8.34 0.33 20.07 0.42 20.26 1.0
kidney
P NS NS
Data are mean SEM. NS = not significant. The P values in the table
refer to comparison between losartan and vehicle in either group.
P < 0.001 compared to control kidney of losartan group and to
vehicle-treated control kidney.
were dissected (naked eye) while in another the procedure was
done under the dissecting microscope and the utmost care taken
to not injure the ureter in any way. This was also done
bilaterally in another rat that had as its comparison a rat that
underwent bilateral free-hand dissection (naked eye). Two
others were ipsilateral controls (C) (rats operated, but ureters
not manipulated). Four additional groups of four rats each were
studied as follows: group A was sham operated; group B was
also sham operated and received treatment with losartan, given
by gavage (10 mg/kg/day) for five days prior to and including the
day of surgery; group C received the converting enzyme
inhibitor (CEI) lisinopril (5 mg/kg/day) by gavage for five days
including the day of UUO; and group D received losartan as
already described for group B before UUO. Four additional
UUO rats were treated with losartan as described above and
GFR, measured by inulin clearance, and effective renal plasma
flow measured by PAH clearance as already described from this
laboratory [11]. Another group of rats (N = 4) received an
equivalent amount of vehicle by gavage for the same period of
time. Losartan was a gift of Dr. Ronald D. Smith, E.I. DuPont
Merck Pharmaceutical (Wilmington, Delaware, USA) and lis-
inopril was a gift of Merck Sharpe and Dohme (West Point,
Pennsylvania, USA).
At the end of the experiments (24 hrs) the rats were sacrificed
with an anesthetic overdose; the kidneys were immediately
removed from all rats except those used for the renal hemody-
namic studies and snap-frozen in liquid nitrogen. Frozen kid-
neys were chiseled into small pieces, which were placed in
guanidium isothiocyanate (GTC), and homogenized immedi-
ately. Samples were then stored at 4°C until analysis.
RNA extraction and Northern hybridization analysis
Total RNA was extracted by the guanidine thiocyanate
method, as previously described [14]. A total of 20 jig RNA was
run on 1% agarose gels using formaldehyde. RNA was trans-
ferred by capillary blotting using standard procedures and
Immobilon-N membranes (charge-modified PVDF transfer
membranes, Millipore Corp., Bedford, Massachusetts, USA).
Blots were washed in 6x SSC for 5 to 10 minutes, then baked
under vacuum for one hour at 80°C.
Table 2. Plasma renin activity measurements
Experimental
groups PRA ngAI/ml/hr N P value
Control (C) 1.3 0.3 5
Sham (S) 1.8 0.3
P = 0.03 vs. (S ÷ Lo)
5 NS




13.4 2.8 4 0.002
(S + Lo)
UUO + vehicle
P = 0.008 vs. (S + V)
3.5 0.8 4 0.04
(UO + V)
NS vs. (S + V) & vs.
(S)
UUO + losartan 77.0 7.0 7 <0.001
(UO + Lo)
P = 0.01 vs. (UO + V)
& vs. (S + Lo)
UUO + lisinopril 78.0 9.0 7 <0.001
(UO + Li)
P = 0.01 vs. (UO + V)
& vs. (S + Lo)
Data are mean SEM. The P value column refers to comparisons
between the respective groups and control (C).
In the Methods section, (S + V), (S + Lo), (UO + V), and (UO + Lo)
are referred to as Groups A, B, C, and D, respectively.
Preparation of riboprobes
AT1 receptor cDNA was originally cloned in the pCDM8
expression vector by Murphy et al [15]. The AT1 receptor
cDNA, a gift of Drs. T.J. Murphy and R. W. Alexander, was
subcloned into pGM4 vector, transcribed and labeled using
32P-UTP (Amershan, Arlington Heights, Illinois, USA), specific
activity 1200 Ci/mmol. A full-length antisense transcript was
used for hybridization.
Labeled riboprobes were prepared using 0.5 to I jig linear-
ized plasmid and a-32P(UTP) or 355(UTP) for Northern blots or
in situ hybridization, respectively. Purified riboprobes were
stored in 70% ethanol at —20°C.
Prehybridization and hybridization
Blots were prehybridized for six hours at 60°C with hybrid-
ization buffer [50% formamide, 5 x SSC (lx SSC:0. 15 M NaCL,
0.015 M Na citrate, pH 7), 8x Denhardt's solution, 1 mM
EDTA, 0.1% sodium pyrophosphate, and 0.5% SDS, 200 jig/mI
denatured salmon sperm DNA]. A mixture of 0.5 to 1.0 x iO
CPM probe in 0.2 ml hybridization buffer was heated to 85°C for
five minutes, then added to 4 ml hybridization buffer and 1 ml
50% dextran sulfate and thoroughly mixed. Hybridization was
carried out overnight (16 to 18 hr) at 60°C. Membranes were
washed for 30 minutes first in 2x SSC + 0.2% SDS at 65°C and
finally in 0.2x SSC + 0.2% SDS at 70°C. Dry blots were
exposed overnight with intensifying screen on Kodak film
xRP-5.
Membrane reprobing
For reprobing with GAPDH cRNA, membranes that had
been previously hybridized were washed in 0.1 N Na OH for 30
minutes at room temperature. A Geiger counter check was
carried out until there was no detectable radioactivity. Then the
AT1 -R—
GAPDH —
1 2 3 4 5 6 7 8
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Fig. 1. Representative autoradiograph of Northern blot (20 jsg RNA/lane). Blots were hybridized with AT1-R cRNA and GAPDH cRNA (lower
bands). Lane I: RNA isolated from a sham kidney whose ureter was grossly dissected (dissection and ligature threading without tying); Lane 2:
RNA isolated from a sham kidney in which microscopic dissection was used to dissect the ureter, otherwise done as described above. The least
"traumatic" dissection led to less down-regulation of the message. Lanes 3, 5, and 7 are the control (right) kidney, while lanes 4, 6, and 8 are the
obstructed (left) kidney of three (each on a different rat) UUO experiments.
membrane was neutralized by immersion in 0.02 M Tris-HCI,
pH 8 + 0.lx SSC + 0.5% SDS for 45 to 60 minutes. The
membranes were then ready to be reprobed. Prehybridization
and hybridization for GAPDH mRNA were performed as
described above.
Densitometry analysis and mRNA quantflcation
The autoradiographs were scanned using the Image Quant'°
computing densitometer (Molecular Dynamics, Sunnyvale, Cal-
ifornia, USA). Results are expressed as relative density. We
used the classical approach of housekeeping gene analysis and
ethidium bromide stain to ascertain equal loading and specific-
ity of response. We have previously shown that UUO does not
alter GAPDH mRNA expresssion [11]. Relative densitometry
was determined by the signal density of each RNA sample
hybridized to the AT1-R riboprobe divided by that hybridized to
the GAPDH probe.
In situ hybridization
The AT1 receptor probe was a full-length antisense cRNA
labeled with 35S-UTP (Amersham), specific activity 1200 Cit
mmol. The experiments were controlled by hybridizing serial
sections with the same cRNA probe transcribed in the sense
orientation. In situ hybridization was performed as previously
described [16, 17]. Briefly, cryosections were prepared with
paraformaldehyde, proteinase K (Sigma Chemical, St. Louis,
Missouri, USA), and prehybridized in 100 ml hybridization
buffer (50% formamide, 0.3 M NaCL, 20 mrs Tris pH 8.0, 5 mM
EDTA, 0.02% polyvinylpyrrolidine, 0.02% Ficoll, 0.02% bo-
vine serum albumin, 10% dextran sulfate, and 10 mrt dithio-
threitol) at 42°C. The hybridizations were performed using
600,000 cpm of 35S-riboprobe at 55°C. After hybridization, the
sections were washed with 2x SSC (lx SSC = 150 mrt NaCI,
15 m Na citrate, pH 7.0) with 10 mrss /3-mercaptoethanol and
1 mrt EDTA, treated with RNase (Sigma), again washed in the
same buffer, followed by a high stringency wash in 0.1 x SSC
with 10 mrs /3-mercaptoethanol and 1 m EDTA, at 52°C. The
slides were then washed in 0.5 x SSC and dehydrated in graded
alcohols containing 0.3 M NH4Ac, dipped in Kodak NTB2
nuclear emulsion, dried in the dark at 4°C with desiccant for two
to eight weeks, and developed at 15°C. Slides were counter-
stained with hematoxylin and eosin.
Analytical procedures
Plasma renin activity (PRA) was measured by determinig the
amount of angiotensin I generated during one hour of incuba-
tion at 37°C in the presence of ACE inhibitors and angiotensi-
nases by radioimmunoassay as previously reported [18].
Statistical methods
Values are expressed as mean SEM. One way analysis of
variance (ANOVA) was used for comparisons between groups.
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Fig. 2. Conditions and gel set-up as in Fig. 1. The upper broken line represents AT1-R mRNA, the lower solid line GAPDH mRNA. The first two
lanes are right and left kidney of grossly bilaterally dissected ureters; the intensity of the bands is equal on both sides, but less than those of the
next two lanes (3 and 4) which are equal to each other and represent RNA from each kidney of one rat after careful (microscopic surgery) dissection
(shams; see text for further detail). These are indistinguishable from the right kidney of the UUO (lanes 5 and 7). Lanes 6 and 8 are the obstructed
kidney (left). It is amply clear that UUO led to down-regulation of the receptor.
Results






Fig. 3. Relative densitometry of Northern blots of RNA from ob-
structed (left, •) and control (right, ) kidneys from 8 rats hybridized
with AT, cRNA. The AT1-R signals have been factored by that of
GAPDH mRNA to which an arbitrary value of one was assigned. AT1-R
in the obstructed kidney was down-regulated by —75% (P < 0.01).
When each animal was used as its own control (left vs. right
kidney) significance was obtained by paired t-test. A value
of P < 0.05 was accepted as significant.
Table 1 shows the results of losartan treatment on effective
renal plasma flow (RPF) and GFR in each kidney of the rats
studied (N = 4). ERPF and GFR improved —fivefold from their
lowest values. GFR in the obstructed kidney rose from a value
of 8% to 37% of the control kidney GFR. ERPF in the
obstructed kidney rose from 12% to a value of 66% of the
control kidney ERPF. Values of GFR and ERPF before and
after losartan were significantly different; both values remained
significantly different from control even after losartan treat-
ment. These results confirm our previous studies using losartan
in UUO [12]. We have also already reported similar results with
lisinopril [19]. Blood pressure fell to similar levels in rats treated
with losartan or lisinopril (80 vs. 88 mm Hg; P =NS), indicating
that the doses of these drugs were comparable in both groups.
Changes in PRA (Table 2) were not significant when shams
were compared to control rats. UUO increased PRA as com-
pared to control animals (P = 0.04); as expected, interruption of
the feedback between Ang II and renin secretion by losartan
and lisinopril markedly increased PRA in sham (not shown for
Li) and UUO rats. In sham rats, losartan increased PRA eight
times over the sham; moreover, PRA was 45 times greater in
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Table 3. Densitometric analysis of AT1-R mRNA autoradiogram signals




Left Right L vs. R L vs. C R vs. C
Control (C) 904 119 866 238 1.0 NS
Sahm (S) 535 61 889 77 0.6 0.01 0.01 NS
Sham + losartan (S + Lo) 1112 157
P = 0.01 vs. S
879 102b 1.3 NS NS NS
UUO (UO) + V 210 95
P = 0.04 vs. S
903 216" 0.2 0.03 0.01 NS
UUO + losartan (UO + Lo) 1058 l40
P = 0.01 vs. UO
922 37b 1.1 NS NS NS
UUO + lisinopril (UO + Li) 523 43
P = 0.02 vs. UO
P = 0.01 vs. UO + Lo
753 9b 0,7 0.04 0.02 NS
Data are mean sEM. Abbreviations are: L, left kidney; R, right kidney.
aNS vs. (S + Lo)b NS vs. S
losartan-treated UUO rats than the average PRA value of all
sham and control rats. PRA parallels the renin secretory rate,
which is partly dependent of RPF; therefore, since ERPF rose
only fivefold, the marked increase in PRA in losartan treated
UUO rats indicates a major intrarenal effect of the inhibitor to
reverse the renin secretion suppressing action of Ang II.
Northern analysis and mRNA quantification
Compared to the contralateral kidney and control ipsilateral
kidneys (as described above), the receptor mRNA signal was
markedly decreased in the obstructed kidney (Figs. 1 and 2).
Densitometry analysis (Fig. 3) revealed the signal to be signif-
icantly lower (—77%) in UUO than in controls. There was no
statistical difference in receptor mRNA expression between the
contralateral and ipsilateral control kidneys (Table 3). Sham
operation, done by free-hand (naked eye) dissection of the left
ureter from its retroperitroneal bed, consistently led to a
decrease in the expression of the AT,-R inRNA in the ipsilateral
kidney compared to the contralateral kidney and to control
ipsilateral kidneys (operated rats whose left ureter was un-
touched; Table 3). AT1-R mRNA expression was decreased by
—40% in the sham kidney compared to the contralateral or
ipsilateral controls. The difference between sham and contralat-
eral and ipsilateral controls was significant and accounted for 25
to 30% of the reduction in steady state AT1-R mRNA concen-
tration, When free-hand unilateral and bilateral dissection was
compared to dissecting microscope-prepared shams (Figs. 1
and 2) free-hand dissection led to reduced expression of the
message while, when careful! ureteral dissection was performed
the signal from that kidney could not be distinguished from
untouched kidneys.
The most striking finding in our experiments is the fact that
both lisinopril and losartan caused a marked increase in the
expression of AT1-R mRNA in the kidney with complete
ureteral obstruction as well as in the kidneys whose ureters
were manipulated (Table 3). By contrast, losartan did not
change the receptor expression in control and contralateral
kidneys. The effects of lisinopril were only examined in UUO,
but the converting enzyme inhibitor consistently led to no
change in the contralateral kidney as compared to controls.
Conversely, it doubled—to normal levels—the AT,-R mRNA
concentration in the obstructed kidney. The effect of losartan
was more dramatic than that of lisinopril. In all instances,
losartan Increased steady state AT1-R mRNA concentrations
from two to five times the values in the untreated sham and the
untreated UUO rats. Moreover, losartan raised receptor
mRNA values two to three times higher than lisinopril.
In situ hybridization studies
In situ hybridization showed localization of AT1-R mRNA
signals in glomeruli and tubules that were more prominent in
contralateral compared to obstructed kidneys. An obstructed
kidney exhibiting sparse signals in both tubules and glomeruli is
shown in Figure 4. Tissue sections from control and sham
kidneys did not differ from each other nor from those of the
contralateral kidneys of rats with UUO (data not shown). While
it is not possible to precisely quantitate the degree of hybrid-
ization signal, these data are in general agreement with the
clear-cut down-regulation of AT,-R mRNA in obstructed kid-
neys without change in expression of the receptor gene in the
contralateral kidney observed by Northern analysis. Sense
AT,-R cRNA did not lead to hybridization signals in any of the
tissues tested (data not shown).
Discussion
The present study shows that 24-hour UUO is associated
with down-regulation of AT1-R gene expression when the ureter
is obstructed or manipulated without careful care not to trau-
matize the area dissected. Careful dissection (under a micro-
scope) of the ureter did not down-regulate the message, which
was also unaltered in control or contralateral kidneys. Suppres-
sion of AT,-R mRNA expression in kidneys with either manip-
ulated (grossly dissected) or obstructed kidneys suggests that
mechanical, humoral, or perhaps neural stimuli arising from the
ureter may operate in the regulation of kidney AT1-R mRNA.
The fact, however, that obstruction resulted in a greater inhi-
bition of steady state mRNA than ureteral manipulation alone,
and that the difference in this measurement between kidneys
with manipulated and obstructed ureters was significant, is
indirect evidence that these two stimuli are capable, possibly by
different mechanisms, of suppressing gene transcription. While
mechanical changes such as alterations in urine flow patterns,
increased pressure and/or stretch of the ureter or of the intra-
renal tubule system, may play a role in the regulation of AT1-R
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FIg. 4. In situ hybridization with a whole length AT, cRNA of control (right; A) and UUO (left; B) kidney section. The arrowhead (A) points to
tubule hybridization which is reduced in B, although some areas in the latter show clumps of signal. Vertical arrows indicate glomerular and macula
densa signals. In B (UUO), the sparse nature of the receptor mRNA can be noted; the abundance of the message was calculated to be twice as
high in the contralateral kidney. The long horizontal arrow points to message in tubules. The short horizontal arrow points to AT1 mRNA
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mRNA expression, the results obtained in animals treated with
losartan or lisinopril suggest that, whatever the initiating step
might be, a hormonal pathway or mechanism is involved.
Moreover, it is clear from our results with losartan and the CEI
lisinopril that Ang II is a critical hormone in the renal regulation
of AT1-R mRNA during obstruction and/or manipulation of the
ureter. It is of interest that Paxton et al [20] found marked
AT1-R immunoreactivity in the smooth muscle cells of the
ureter and renal pelvis of both Wistar and Sprague-Dawley rats,
suggesting a role for Ang II in the contractility of these
structures. It is conceivable that the presence of these Ang II
responsive cells may be related to the changes in receptor gene
expression in the kidney after manipulation or obstruction of
the ureter, the nature of which remains to be uncovered. Kopp
and her associates [21, 22] have shown that acute UUO, albeit
of short duration (30 to 40 mm), increases ipsilateral afferent
renal nerve activity and decreases contralateral efferent renal
nerve activity. The sensory receptors activated by these inter-
ventions have been localized to the renal pelvis [211. Further-
more, inhibitory reno-renal reflexes in response to mechanical
and chemical activation of these receptors are prostaglandin-
mediated [22]. It is well known that a close interrelationship
exists among prostaglandins, renin secretion and thus the
response to Ang II in UUO [23, 24]. The full significance,
however, of the renal nerves and of mechanical alterations in
ureteral and pelvic functions in the regulation of the renal
expression of AT1-R mRNA remains to be clarified. Neverthe-
less, in view of the fact that ureteral manipulation reduced
ipsilateral renal AT1-R gene expression, we suggest the possi-
bility that afferent renal nerve activity serves a role in the
regulation of this and perhaps other genes in the RAS cascade.
Inasmuch as 24-hour UUO may be compared to 30 minute
UUO, and in view of the lack of change in AT1-R mRNA,
diminished efferent renal nerve activity in the contralateral
kidney does not seem to affect regulation of this gene.
A recent study by El-Dahr and collaborators [10] has shown
that chronic UUO increases ipsilateral renin mRNA, but leads
to down-regulation of kallikrein gene expression, increased
plasma ACE-kininase II and reduced immunoreactive kallikrein
content in the ipsilateral kidney. In addition, we have shown an
increase in both renin and ACE mRNAs expression in acute
UUO [11]. These results suggest a role for bradykinin in the
intrarenal regulation of RAS genes. Lisinopril, which by inhi-
bition of ACE-kininase II should increase local bradykinin
production, was less effective in restoring AT1-R mRNA than
losartan, which does not alter bradykinin production [25]. This
may be indicative of an AT1-R gene suppressive effect of
bradykinin and further suggests the possibility of at least a
permissive role of the kallikrein system in the intrarenal regu-
lation of the RAS.
Reduced steady state levels of AT1-R mRNA in acute UUO
would lead to decreased transcription rate, diminished synthe-
sis of receptor molecules, and diminished response to locally
generated Ang II. Our findings of a reduced renal receptor
mRNA concentration are in keeping with the elevated plasma
renin activity (and presumably Ang II levels) in the early phases
of UUO since Ang II would lead to down-regulation of its
receptor in the kidney [26, 27]. Receptor down-regulation
would be potentiated by the increased intrarenal Ang II pro-
duction which has been shown to occur in response to UUO
[10, 13]. The restoration and enhancement of receptor gene
expression, the partial but significant hemodynamic recovery
and the dramatic increase in PRA induced by both losartan and
lisinopril treatment in UUO, are in keeping with the proposal of
the principal role of Ang II in down-regulation of receptor gene
expression and receptor synthesis.
In a previous study, we found that UUO leads to an early rise
in plasma renin activity and to marked elevations in the steady
state concentration of renin mRNA as determined by Northern
analysis [11]. In addition, it was shown that vascular endothe-
liusn and perivascular fat exhibited increased expression of
ACE and angiotensinogen mRNA, respectively. Thus the cru-
cial first 24 hours of obstruction are accompanied by increased
expression of the mRNAs for renin, angiotensinogen, angiotensin
converting enzyme and, possibly, increased angiotensm II pro-
duction which eventually down-regulates the receptor mRNA.
These findings indicate that the intrarenal RAS is regulated by
some component of the obstructive process and, in view of the
response to losartan, that Ang II contributes in a major way to
the hemodynamic alterations observed.
In summary, we conclude that acute (24 hr) UUO leads to
increased intrarenal production of Ang II which is responsible
for the hemodynamic changes and down-regulation of the
AT1-R mRNA in the obstructed kidney. The increased Ang II
synthesis results from enhanced expression of renin, angioten-
sinogen and angiotensin I-converting enzyme mRNAs in UUO
[11]. Some function of UUO, possibly stretch or pressure,
differentially regulates the genes encoding for the renin-angio-
tensin system.
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